HIPACE High Frequency Low Energy Pacing to Terminate Fast Ventricular Arrythmias
HIPACE
High Frequency Low Energy Pacing to Terminate Fast Ventricular Arrythmias
1 other identifier
interventional
8
1 country
1
Brief Summary
People that have survived, or are at high risk of a lifethreatening ventricular arrhythmia are routinely offered a defibrillator (ICD). An ICD is an implanted device which can recognise a ventricular arrhythmia and then try to treat it, either by rapidly pacing the heart or by shocking the heart. Currently, very fast ventricular arrhythmias, known as VF, can only be treated with a shock. Patients find shocks painful and this study is intended to find out whether it is possible to pace the heart at very high rates during VF. It is hoped that if this is possible, further research could lead to effective treatment of VF with pacing rather than shocks, and therefore better outcomes for patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 10, 2015
CompletedFirst Posted
Study publicly available on registry
December 14, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2016
CompletedFebruary 28, 2019
February 1, 2019
9 months
December 10, 2015
February 26, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Rapid pacing of the heart
The primary outcome measure is to determine whether it is possible to obtain ventricular capture of the heart by repetitive pacing at very high rates during ventricular fibrillation.
10 seconds
Interventions
Defibrillation testing of cardiac defibrilator
Eligibility Criteria
You may qualify if:
- Patient is older than 18 years of age; Any patient with a Medtronic cardiac implantable defibrillator undergoing defibrillation testing; No contra indication to defibrillation testing Patient is able to give informed consent.
You may not qualify if:
- Patient is younger than 18 years; Patient is not able to give informed consent or is unwilling to participate in the study; Patient has a contraindication to defibrillation testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leeds Teaching Hospitals NHS Trust
Leeds, West Yorkshire, LS2 9LN, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2015
First Posted
December 14, 2015
Study Start
November 1, 2015
Primary Completion
July 29, 2016
Study Completion
July 29, 2016
Last Updated
February 28, 2019
Record last verified: 2019-02